# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-035419
Filing Date
2024-03-22
Accepted
2024-03-22 16:42:12
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | inva-20231231.htm iXBRL | 10-K/A | 271554
2 | EX-23.3 | inva-ex23_3.htm | EX-23.3 | 2858
3 | EX-31.1 | inva-ex31_1.htm | EX-31.1 | 13666
4 | EX-31.2 | inva-ex31_2.htm | EX-31.2 | 13005
5 | EX-32 | inva-ex32.htm | EX-32 | 14273
6 | EX-99.1 | inva-ex99_1.htm | EX-99.1 | 723545
| Complete submission text file | 0000950170-24-035419.txt |  | 5029987

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | inva-20231231.xsd | EX-101.SCH | 2726588
20 | EXTRACTED XBRL INSTANCE DOCUMENT | inva-20231231_htm.xml | XML | 11223

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 24775863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)